Steven VAN CRUCHTEN
Steven Van Cruchten obtained his DVM degree at Ghent University in 1999 and started his PhD research in reproductive morphology at the same university. After his PhD defense in 2004, he was recruited as a developmental and reproductive toxicologist (DART) by Janssen in Belgium. In January 2008, he took the opportunity to join AstraZeneca in Sweden as a DART expert. He returned to Belgium in 2011 at the University of Antwerp and he is currently a full-time tenured professor focusing his research on predicting exposure and potential safety issues of pharmaceuticals in pregnant women and children. He is a European Registered Toxicologist, Past President of the European Teratology Society and President of the Belgian Society of Toxicology and Ecotoxicology. He is Associate Editor of the journals Reproductive Toxicology, Frontiers in Toxicology (DART section) and Animals. Besides his research activities, he is responsible for several courses within the bachelor programme of Veterinary Medicine, the master programme of Pharmaceutical Sciences and the bachelor and master of Biomedical Sciences. He is currently Vice-Chair of the Department of Veterinary Sciences at UAntwerp and is member of several institutional boards and (inter-)university committees.
For a full list of publications and projects see https://www.uantwerpen.be/en/staff/steven-vancruchten/research/
Jeanne PERRIN
Médecin spécialisé en Biologie de la Reproduction et du Développement, responsable du...
Virginie RIGOURD
Virginie Rigourd est une pédiatre néonatologiste reconnue. Diplômée de l'Université Paris XI,...
Christophe DE LA ROCHE SAINT-ANDRE
Ancien normalien, Christophe de La Roche Saint-André est titulaire d’un doctorat en biologie. Il...
Fabien LAVERGNE
Pharmacien de formation, Fabien Lavergne est évaluateur non-clinique à l'Agence Nationale de...
Romain GRALL
Romain Grall est un pharmacien et toxicologue français, actuellement responsable du Laboratoire...
Elisabeth ELEFANT
Praticien hospitalier à l'Université Paris Sorbonne, APHP (1981-2023) et en cumul...